{{Rsnum
|rsid=1501908
|Chromosome=5
|position=156971158
|Orientation=minus
|GMAF=0.3843
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 7.1 | 45.1 | 47.8
| HCB | 8.1 | 34.6 | 57.4
| JPT | 1.8 | 27.4 | 70.8
| YRI | 38.8 | 49.7 | 11.6
| ASW | 35.1 | 47.4 | 17.5
| CHB | 8.1 | 34.6 | 57.4
| CHD | 8.3 | 42.2 | 49.5
| GIH | 14.9 | 45.5 | 39.6
| LWK | 56.4 | 36.4 | 7.3
| MEX | 6.9 | 37.9 | 55.2
| MKK | 44.5 | 48.4 | 7.1
| TSI | 9.8 | 52.9 | 37.3
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19060906
|Trait=LDL cholesterol
|Title=Common variants at 30 loci contribute to polygenic dyslipidemia
|RiskAllele=G
|Pval=1E-11
|OR=0.07
|ORtxt=[0.03-0.11] SD decrease
|OA=1
}}

{{PharmGKB
|RSID=rs1501908
|Name_s=
|Gene_s=TIMD4
|Feature=
|Evidence=PubMed ID:19060906; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Common variants at 30 loci contribute to polygenic dyslipidemia. (Initial Sample Size: 19,840 individuals; Replication Sample Size: Up to 20,623 individuals); (Region: 5q33.3; Reported Gene(s): TIMD4, HAVCR1; Risk Allele: rs1501908-G); (p-value= 0.00000000001).This variant is associated with LDL cholesterol.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740254
}}

{{PMID Auto
|PMID=19951432
|Title=Analysis of recently identified dyslipidemia alleles reveals two loci that contribute to risk for carotid artery disease.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1501908
|overall_frequency_n=76
|overall_frequency_d=128
|overall_frequency=0.59375
|n_genomes=43
|n_genomes_annotated=0
|n_haplomes=64
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}